More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-26.9% Growth)
- Ratings (7.4 Score)

Upcoming Events

- Earnings (8/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 90.97 +0.43 (0.47%)
Prev. Close $90.54  
Open$91.11 
52 Wk High$ 
52 Wk Low$ 
Day High$92.21 
Day Low$90.60 
P/E N/A  
EPS$ 
Volume484,122 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, CVAC, NVAX (more...)

Jun 15, 2026 06:08 AM German government to drop variable drug discounting plans - Reuters
Jun 8, 2026 08:01 AM Form 6-K BioNTech SE For: Jun 08
Jun 5, 2026 09:00 AM Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)
Jun 3, 2026 01:17 PM Lilly cuts Germany investment plan in half over healthcare reforms
Jun 3, 2026 09:29 AM The Multi-Billion-Dollar Search for Better Glioblastoma Treatments
Jun 1, 2026 08:00 AM Form 6-K BioNTech SE For: Jun 01
May 28, 2026 04:07 PM JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 27, 2026 04:21 AM UBS Upgrades BioNTech (BNTX) to Buy
May 22, 2026 08:03 AM Form 6-K BioNTech SE For: May 22
May 22, 2026 05:00 AM BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting
View All Articles

Entities mentioned with BNTX

View All Entities